A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia

Clinical trial NCT04102501 · COMPLETED

Trial details

NCT number: NCT04102501
Sponsor: Biojiva LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Friedreich's Ataxia

Start date: 2019-10-30
Primary completion: 2021-08-23
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.